SCHEMBL23948718

SCHEMBL23948718

c1ccc2c(c1)[nH]c1c2ccc2c1c1cnccc1n1c3cccnc3nc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.40
TDO2 P48775 3/20 0.40
CDK5 Q00535 2/20 0.39
DYRK1A Q13627 2/20 0.39
CDK5R1 Q15078 2/20 0.39
CLK1 P49759 1/20 0.39
CLK2 P49760 1/20 0.39
CLK3 P49761 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
DYRK1B Q9Y463 1/20 0.39
GABRA1 P14867 6/20 0.38
GABRG2 P18507 6/20 0.38
GABRB3 P28472 6/20 0.38
GABRA5 P31644 6/20 0.38
GABRA3 P34903 6/20 0.38
GABRA2 P47869 6/20 0.38
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 3/20 0.38
HPGD P15428 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23949002 0.92 TDO2 (0.42) ACHETDO2CDK5DYRK1ACDK5R1
SCHEMBL23948946 0.91 GABRA1 (0.41) TDO2GABRA1GABRG2GABRB3GABRA5
SCHEMBL23948911 0.87 GABRA1 (0.41) ACHETDO2GABRA1GABRG2GABRB3
SCHEMBL23948669 0.85 GABRA1 (0.44) TDO2GABRA1GABRG2GABRB3GABRA5
SCHEMBL23948719 0.85 ACHE (0.40) ACHETDO2CDK5DYRK1ACDK5R1
SCHEMBL23948668 0.84 ACHE (0.43) ACHETDO2CDK5DYRK1ACDK5R1
SCHEMBL23948617 0.84 ACHE (0.43) ACHETDO2CDK5DYRK1ACDK5R1
SCHEMBL23948798 0.82 GABRA1 (0.40) ACHETDO2CDK5DYRK1ACDK5R1
SCHEMBL23948682 0.81 TDO2 (0.41) ACHETDO2CDK5DYRK1ACDK5R1
SCHEMBL23948217 0.80 GABRA1 (0.40) ACHETDO2CDK5DYRK1ACDK5R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210323963-A1 Functional Materials Based on Stable Chemical Structure ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323963-A1 Functional Materials Based on Stable Chemical Structure TEAD4, TEAD2, TEAD1 ACHE 1059/4885TDO2 224/4885CDK5 3647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.